Clearance of amyloid-beta by circulating lipoprotein receptors - Wikidata - wikimedia - TriplyDB

Clearance of amyloid-beta by circulating lipoprotein receptors

Clearance of amyloid-beta by circulating lipoprotein receptors

http://www.wikidata.org/entity/Q24613781

about

SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Biological markers of amyloid beta-related mechanisms in Alzheimer's disease Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1 Type 2 diabetes and cognitive impairment: linking mechanisms The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease Intravenous immunoglobulin and Alzheimer's disease: what now?Oxidized cholesterol as the driving force behind the development of Alzheimer's disease Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer's disease with aging.Mapping the interactions between the Alzheimer's Aβ-peptide and human serum albumin beyond domain resolution.Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels.Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Biomarkers in Alzheimer's disease: past, present and future.Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice.C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65 Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.The effects of cholesterol on learning and memory.Circulating neprilysin clears brain amyloid Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid Cholesterol increases ventricular volume in a rabbit model of Alzheimer's disease.Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid

P2860

Q24309440-805BD958-CD2F-406C-8C59-4E235EF87FC8 Q24604376-2BCDF4A3-F512-40B9-A621-2620283DD672 Q24622136-05E60724-18DE-4350-AAF9-56FB7B0F96D8 Q26800063-FAA085D1-902A-48BA-A148-6E32865A9B5F Q26822993-9220B7F1-FA7A-4BF0-BBD4-A88302215AB1 Q26827353-5C5A55EC-D8EA-44C8-B8DA-9B9FE102FA45 Q26858870-321BC0A4-5629-4C16-9F9C-29CAB9E9AAB7 Q27000371-11FEB24C-76BF-42E3-B8CE-E3C033567950 Q27023315-06409D4E-3941-4A47-83D3-74415899115B Q27332086-04D8B4A9-9279-46F7-837A-0F3A741BD337 Q28081678-94E79B2A-77FC-4D87-9B9B-2941740C919E Q28261647-1DF1F474-D2D8-4F98-A8C4-4416FFC7A119 Q28582464-1E7843B7-9576-475E-993B-B6CF04D49C88 Q29615839-DEAC5852-31E2-400C-9404-8FBDE4FC4129 Q29976923-38EBAC1E-39DD-406F-9328-58F664BB056E Q30275974-E30C8408-9CE7-4BE7-8AF1-4FB8DF613733 Q30495250-A0C6C836-E312-4E5D-86C9-01C7E39126DD Q30559265-BA485E83-09ED-4BCD-A244-CB45FA79A6BB Q30587668-B9778EE8-497D-48AB-8695-6D0B209A31E6 Q30671407-B40988EC-7791-4C97-9CE8-DA86E1ACDA43 Q30703354-9D84C1A0-03CC-4A99-86C5-9766153C0E20 Q30814231-101B0CEE-380D-44AD-BB2B-491C8E45BB9E Q33496258-9849B5D8-F037-4FA6-9837-BC8FB309BAFA Q33625476-775BCF41-BB29-4599-B248-50C7545276DE Q33713881-5D4F3234-392D-4448-A091-813F4DCF0D3B Q33782706-0FF3153B-6BA3-4F0A-852C-27AEEBB4226F Q33791646-CDFF3043-45D1-4E79-BFF2-0588EC7E8C14 Q33819768-9E9FC268-A7AC-465C-873B-B3CD5018F739 Q33827931-4E5DA8BD-0A3E-4D5A-8567-DD272D18B1E4 Q33854483-2127C7FB-5B0B-4988-93F4-92D4AB62FE10 Q33895840-EFC8DE58-E89C-4FFA-AFB7-1BB3A7FC882B Q33959032-ABA027B9-AA41-4E0E-9A33-A8ED083107E4 Q33976829-CD05C3C1-5A7D-4CA2-96E6-FEFFA33C910A Q34071954-6ED9E26B-2AC2-4FEE-9397-052689A00208 Q34078408-AA93D64D-2645-4249-B286-A37480F5ED3B Q34122488-62C3E824-709A-4476-B37E-95D1769CC615 Q34268519-E248CAB0-93B9-40C1-8022-769B33B21997 Q34273807-4CF3FBF1-50B2-4BB8-83B9-8BF8ADCC6DD5 Q34274025-3B01EFC3-005F-40BD-B0BB-F8A139793F3C Q34286389-7902B34F-9893-403B-BAD9-B124D108E4C6

P2860

Clearance of amyloid-beta by circulating lipoprotein receptors

http://www.wikidata.org/entity/Q24613781

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Clearance of amyloid-beta by circulating lipoprotein receptors

@ast

Clearance of amyloid-beta by circulating lipoprotein receptors

@en

Clearance of amyloid-beta by circulating lipoprotein receptors

@nl

type

label

Clearance of amyloid-beta by circulating lipoprotein receptors

@ast

Clearance of amyloid-beta by circulating lipoprotein receptors

@en

Clearance of amyloid-beta by circulating lipoprotein receptors

@nl

prefLabel

Clearance of amyloid-beta by circulating lipoprotein receptors

@ast

Clearance of amyloid-beta by circulating lipoprotein receptors

@en

Clearance of amyloid-beta by circulating lipoprotein receptors

@nl

P1433

Q24613781-9AA40403-F59A-4CF4-B758-64EFDE0DD91C

P1476

Q24613781-031E204D-A3E7-4677-9067-9AB7C7C5A9A4

P2093

Q24613781-0F728BD1-47A2-446C-A68D-90B6B99BAC93

Q24613781-2BE6A51D-2B53-4575-872A-4F54790D5BB4

Q24613781-30B13955-5C04-47FE-A58B-DFEF2370AFCF

Q24613781-32E4956A-CB98-430B-954C-A815C6BB61A5

Q24613781-5972D7FC-AA05-49BE-968D-DC8752A09D13

Q24613781-6E745BF8-17E7-4BF9-A863-8222BC06EA84

Q24613781-6EE93BA2-317B-4DB7-BE43-63BED27ACE4F

Q24613781-7CE3602B-3600-4D24-B838-F1CE25488900

Q24613781-B1D3BC55-35EB-4346-B4FA-5CE084A5A392

Q24613781-B7AD7CAC-A7C1-4A9E-BF7E-8EB21DD3402A

P2860

Q24613781-0F2AAB9F-0596-4E5C-9DD2-7C302C34B9DE

Q24613781-0FDEBE94-34D2-4560-B3DF-398D6D6EF3C7

Q24613781-0FFB3018-7CEC-4E21-B4DC-A3EE6CBAE62F

Q24613781-21E1FCD3-6A34-4283-906C-2A53CFDF5438

Q24613781-2E41C2F8-ABC0-45E0-B8E3-65CD38E5DAA3

Q24613781-4167666B-19A4-4235-BFFE-F8BC7A6CA5E6

Q24613781-6C78104D-87F1-45A7-A9E1-BA8A738A7B34

Q24613781-6D828A6F-E509-46D8-93F4-58F7F972CF04

Q24613781-880C9026-E558-40B8-9B1E-B2E7315A5ADF

Q24613781-9858775A-D6E7-4678-AF95-1697D42B891C

P2888

Q24613781-E5594ABF-BF16-47CD-9972-2B4F75932C27

P304

Q24613781-E659F812-703C-401E-9821-22AA35D0E656

P31

Q24613781-202E40DC-906F-48D4-A254-F7DE65B73893

P3181

Q24613781-C6BE7B48-C776-43EC-81D4-2C2EEBC6BA06

P356

Q24613781-917C5868-FC83-4EBC-851B-9B3729D4A859

P407

Q24613781-B4B91484-E06D-4CC7-9DCD-BE526C36BAC4

P433

Q24613781-328D521F-313E-4B9C-850B-86862D9934F5

P478

Q24613781-FC479CF2-F5DD-4B29-ABAE-60688C5EBE3D

P50

Q24613781-04FB8B05-5A6A-475A-889B-FF00542DCAD4

Q24613781-3AFD0847-60DB-494F-AF04-2DD1ACDEC10E

Q24613781-ED61CA12-F476-4627-B833-C84094C56082

P577

Q24613781-F58184FE-8623-448D-9189-67C5D207590A

P5875

Q24613781-DE2EDAE5-AF73-4066-AF2B-90D996285E50

P6179

Q24613781-3B411F1D-A713-424F-8B88-8D3502D90D14

P698

Q24613781-14AF3978-87C9-47FB-87E0-43E7F79DFE40

P921

Q24613781-E8E861CD-5A35-4FB4-8AA8-98DA0C36D05C

P932

Q24613781-C14335FB-1233-4B34-9BF9-B318B993B8F1

P3181

P356

P1433

Nature Medicine

P1476

Clearance of amyloid-beta by circulating lipoprotein receptors

@en

P2093

Abhay Sagare

http://www.w3.org/2001/XMLSchema#string

Andrew Marky

http://www.w3.org/2001/XMLSchema#string

Berislav V Zlokovic

http://www.w3.org/2001/XMLSchema#string

Bradley Johnson

http://www.w3.org/2001/XMLSchema#string

Katie Hamm

http://www.w3.org/2001/XMLSchema#string

Kevin Mayo

http://www.w3.org/2001/XMLSchema#string

Mireia Coma

http://www.w3.org/2001/XMLSchema#string

Rashid Deane

http://www.w3.org/2001/XMLSchema#string

Robert D Bell

http://www.w3.org/2001/XMLSchema#string

Ronan Pendu

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma

Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls

Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

LRP and Alzheimer's disease.

The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate.

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

Binding site structure of one LRP-RAP complex: implications for a common ligand-receptor binding motif.

P2888

P304

1029-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

290570

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NM1635

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

David Perlmutter

Peter J Lenting

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6145607

http://www.w3.org/2001/XMLSchema#string

P6179

1006313139

http://www.w3.org/2001/XMLSchema#string

P698

17694066

http://www.w3.org/2001/XMLSchema#string

P921

P932

2936449

http://www.w3.org/2001/XMLSchema#string